EUVIMEDScopri EUVIMED
Open access

Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis

Sean W Cutter iD, Gang Liu iD, Eleanor Saunders, Bailey Cardwell iD, Vinzenz Hofferek, Thomas Soerianto iD, Kaitlyn Ritchie, Erin N S McGowan, Tien K Nguyen iD, Ivan K H Poon iD, Malcolm J McConville iD, Benjamin J Marsland and 6 more

Science Advances · 2026-07-17 · 12 (29)

DOI: 10.1126/sciadv.aec8501 ↗

At a glance

Journal article in Science Advances, published on 2026-07-17. Written by Sean W Cutter and 17 co-authors. Institution: Centre for Cardiovascular Biology and Disease Research, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria 308…. Major MEDLINE topics: Vitronectin, Macrophages, Idiopathic Pulmonary Fibrosis. Cited 1 times so far (Crossref); 105 references. The full text is freely available in PubMed Central. Funded by: Australian Research Council, National Health and Medical Research Council, National Heart Foundation of Australia.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Macrophages are key drivers of inflammatory and fibrotic diseases, and their activation is shaped by interactions in their tissue microenvironment. However, dissecting the processes that drive immunopathology has proved challenging, as traditional two-dimensional (2D) culture methods fail to capture the complex molecular environment that macrophages inhabit in vivo. To address this, we generated a 3D in vitro model to better mimic the in vivo biophysical microenvironment. We show that the extracellular matrix protein vitronectin promotes a previously unknown profibrotic macrophage phenotype in 3D that is characterized by increased expression of the nicotinamide adenine dinucleotide (NAD + ) ectoenzyme CD38, elevated glycolysis and mitochondrial metabolism, and synthesis of the immunomodulatory metabolite itaconate. This is validated in vivo where patients with idiopathic pulmonary fibrosis have elevated vitronectin and MRC1 + CD38 + macrophages, while vitronectin-deficient mice were protected from an experimental model of lung injury and fibrosis. Thus, we uncover a previously unidentified link between the composition of tissue niches and macrophage profibrotic function via altered metabolic reprogramming.

Subjects

MeSH terms (MEDLINE)

VitronectinMacrophagesIdiopathic Pulmonary FibrosisAnimalsMiceHumansMetabolic ReprogrammingDisease Models, AnimalCell Culture Techniques

Substances

Vitronectin

Authors and institutions

  • Centre for Cardiovascular Biology and Disease Research, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria 3086, Australia.
  • Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Victoria 3086, Australia.
  • School of Life Sciences, Faculty of Science, University Technology Sydney, Ultimo, New South Wales 2007, Australia.
  • Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria 3004, Australia.
  • Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria 3004, Australia.

ORCID profiles: Sean W Cutter, Gang Liu, Bailey Cardwell, Thomas Soerianto, Tien K Nguyen, Ivan K H Poon, Malcolm J McConville, Glen P Westall, Mark D Hulett, Nicholas P Reynolds, Mark D Wright, Philip M Hansbro, Katrina J Binger

Funding

  • Australian Research Council
  • National Health and Medical Research Council
  • National Heart Foundation of Australia
  • Rebecca L. Cooper Medical Research Foundation
  • La Trobe University
  • University of Technology Sydney
  • Lung Foundation Australia
  • Sir Edward 'Weary' Dunlop Medical Research Foundation

Cite

APA

Cutter, S. W., Liu, G., Saunders, E., Cardwell, B., Hofferek, V., Soerianto, T., Ritchie, K., McGowan, E. N. S., Nguyen, T. K., Poon, I. K. H., McConville, M. J., Marsland, B. J., Westall, G. P., Hulett, M. D., Reynolds, N. P., Wright, M. D., Hansbro, P. M., & Binger, K. J. (2026). Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis. Science Advances, 12(29). https://doi.org/10.1126/sciadv.aec8501

Vancouver

Cutter SW, Liu G, Saunders E, Cardwell B, Hofferek V, Soerianto T, et al. Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis. Science Advances. 2026;12(29). doi:10.1126/sciadv.aec8501

BibTeX
@article{Cutter2026,
  author = {Cutter, Sean W and Liu, Gang and Saunders, Eleanor and Cardwell, Bailey and Hofferek, Vinzenz and Soerianto, Thomas and Ritchie, Kaitlyn and McGowan, Erin N S and Nguyen, Tien K and Poon, Ivan K H and McConville, Malcolm J and Marsland, Benjamin J and Westall, Glen P and Hulett, Mark D and Reynolds, Nicholas P and Wright, Mark D and Hansbro, Philip M and Binger, Katrina J},
  title = {Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {29},
  doi = {10.1126/sciadv.aec8501}
}
Start for free →